How we treat endocrine complications of immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) are antibodies that target certain immune checkpoints (ICs), such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death 1 (PD-1) or its ligand (PD-L1), and have emerged as a powerful new tool for oncologists. As these immune checkpoints are cru...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESMO Open
Auteurs principaux: Paschou, S.A., Stefanaki, K., Psaltopoulou, T., Liontos, M., Koutsoukos, K., Zagouri, F., Lambrinoudaki, I., Dimopoulos, M.-A.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807832/
https://ncbi.nlm.nih.gov/pubmed/33399077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2020.100011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires